RhumbLine Advisers’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.46K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $132K | Sell |
|
|||||
|
2021
Q4 | $234K | Sell |
|
|||||
|
2021
Q3 | $257K | Buy |
|
|||||
|
2021
Q2 | $346K | Sell |
|
|||||
|
2021
Q1 | $383K | Sell |
|
|||||
|
2020
Q4 | $351K | Buy |
|
|||||
|
2020
Q3 | $284K | Sell |
|
|||||
|
2020
Q2 | $319K | Buy |
|
|||||
|
2020
Q1 | $154K | Hold |
|
|||||
|
2019
Q4 | $198K | Buy |
|
|||||
|
2019
Q3 | $192K | Sell |
|
|||||
|
2019
Q2 | $178K | Buy |
|
|||||
|
2019
Q1 | $216K | Sell |
|
|||||
|
2018
Q4 | $211K | Buy |
|
|||||
|
2018
Q3 | $266K | Sell |
|
|||||
|
2018
Q2 | $301K | Buy |
|
|||||
|
2018
Q1 | $303K | Buy |
|
|||||
|
2017
Q4 | $406K | Sell |
|
|||||
|
2017
Q3 | $704K | Buy |
|
|||||
|
2017
Q2 | $653K | Buy |
|
|||||
|
2017
Q1 | $379K | Buy |
|
|||||
|
2016
Q4 | $269K | Buy |
|
|||||
|
2016
Q3 | $208K | Buy |
|
|||||
|
2016
Q2 | $192K | Buy |
|
|||||
|
2016
Q1 | $186K | Buy |
|
|||||
|
2015
Q4 | $232K | Buy |
|
|||||
|
2015
Q3 | $198K | Buy |
|
|||||
|
2015
Q2 | $256K | Buy |
|